A study funded by a Canadian biopharmaceutical company estimates that the combined health-care and productivity costs to Canada from verotoxigenic E. coli-related (VTEC) infections total about $404 million per year. The peer-reviewed study, to be
Continue Reading Study: E. Coli Infections Cost Canada $400 Million Annually
Cargill Field Tests E. coli Vaccine
A dozen or so feedlots around the Fort Morgan, CO beef plant owned by Cargill Meat Solutions have been enlisted in a field trial for a vaccine against E. coli O157:H7.
The plan, according to
Field Tests Planned for E. coli Vaccines
Whether new vaccines against E. coli O157:H7 can work well enough to be economically viable could be decided by new large field trials that are just getting underway.
Two vaccines are in trial. Willmar, MN-based